Find comprehensive information on documenting a history of chemotherapy in healthcare settings. This resource covers clinical documentation best practices, medical coding guidelines for chemotherapy history, including ICD-10 codes, Z codes, and SNOMED CT terms. Learn how to accurately record prior chemotherapy regimens, dates, responses, and adverse effects for improved patient care and accurate billing. Explore resources for oncologists, nurses, medical coders, and other healthcare professionals seeking guidance on documenting a patient's history of chemotherapy treatment.
Also known as
Personal history of malignant neoplasm
Indicates a past diagnosis of cancer, now treated or in remission.
Personal history of chemotherapy
Identifies a patient's past experience with chemotherapy treatment.
Encounter for antineoplastic chemotherapy
Used for encounters specifically related to receiving chemotherapy.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the encounter for the chemotherapy itself?
Yes
Do NOT code Z85.1. Code the appropriate malignant neoplasm code and the appropriate chemotherapy administration code.
No
Is there a current malignant neoplasm?
When to use each related code
Description |
---|
History of chemotherapy |
Adverse effect of chemotherapy |
Neutropenia due to chemotherapy |
Coding Z85.1 requires specifying the type of chemo received. Lack of detail can lead to denials and inaccurate quality data.
Confusing active treatment (e.g., Z51.1) with history (Z85.1) leads to inaccurate reporting and potential billing errors.
Vague documentation makes it difficult to distinguish between history of chemo and other related conditions, impacting code selection.
Patient presents with a history of chemotherapy for [Primary cancer diagnosis, e.g., breast cancer, non-Hodgkin's lymphoma, acute myeloid leukemia]. The patient completed a regimen of [Specific chemotherapy regimen, e.g., CHOP, R-CHOP, FOLFOX, BEACOPP] from [Start date] to [End date]. This regimen consisted of [List specific chemotherapeutic agents, e.g., cyclophosphamide, doxorubicin, vincristine, prednisone]. The patient tolerated the chemotherapy [Well, moderately, poorly] and experienced [List specific side effects, e.g., neutropenia, nausea, vomiting, alopecia, mucositis, peripheral neuropathy, cardiotoxicity]. [Specify if any dose reductions or treatment delays were necessary due to side effects]. Current symptoms related to prior chemotherapy include [List ongoing symptoms, e.g., fatigue, neuropathy, cognitive impairment]. Physical exam findings relevant to prior chemotherapy are [Document relevant findings, e.g., decreased sensation in extremities, signs of cardiac dysfunction]. The patient's current performance status is [ECOG performance status, Karnofsky performance status]. Assessment includes history of chemotherapy-induced [Specific long-term complications, e.g., peripheral neuropathy, cardiomyopathy, secondary malignancy]. Plan includes continued surveillance for late effects of chemotherapy, including [Specify monitoring plan, e.g., echocardiograms, neurological exams, complete blood counts]. Patient education provided regarding management of long-term side effects and importance of follow-up care. ICD-10 code Z85.1 (personal history of malignant neoplasm) and Z92.21 (personal history of chemotherapy] are applicable. Medical billing codes will be determined based on the specific services provided during this encounter.